All the most promising drugs approved by FDA in 2017 and their future potential
In 2017, the Center for Drug Evaluation and Research (CDER) of FDA approved 46 novel drugs. This represents a significant growth compared to the 22 new novel medications approved in 2016. The positive trend of approval in 2017 signifies that we are still going to see many novel drug launches in 2018.
Here is the list of the most promising drugs approved in 2017 that have been recently launched or will be launched in 2018:
Sources: Annual reports, SEC filings, Press releases, Company websites, U.S. FDA website
Luca Dezzani is a Novartis employee. All the views, analysis, and perspectives are fully independent and belongs to the author only. They do not represent the views or opinions of Novartis or any other company or organization. IgeaHub is a pharmaceutical blog created and curated by Luca Dezzani. IgeaHub does not receive any funding or support from Novartis or any other pharmaceutical company.